1. Home
  2. INZY vs DTI Comparison

INZY vs DTI Comparison

Compare INZY & DTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • DTI
  • Stock Information
  • Founded
  • INZY 2015
  • DTI 1984
  • Country
  • INZY United States
  • DTI United States
  • Employees
  • INZY N/A
  • DTI N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • DTI Metal Fabrications
  • Sector
  • INZY Health Care
  • DTI Industrials
  • Exchange
  • INZY Nasdaq
  • DTI Nasdaq
  • Market Cap
  • INZY 64.9M
  • DTI 68.0M
  • IPO Year
  • INZY 2020
  • DTI N/A
  • Fundamental
  • Price
  • INZY $3.97
  • DTI $2.62
  • Analyst Decision
  • INZY Buy
  • DTI Strong Buy
  • Analyst Count
  • INZY 9
  • DTI 1
  • Target Price
  • INZY $15.22
  • DTI $5.50
  • AVG Volume (30 Days)
  • INZY 5.3M
  • DTI 56.0K
  • Earning Date
  • INZY 05-14-2025
  • DTI 05-13-2025
  • Dividend Yield
  • INZY N/A
  • DTI N/A
  • EPS Growth
  • INZY N/A
  • DTI N/A
  • EPS
  • INZY N/A
  • DTI N/A
  • Revenue
  • INZY N/A
  • DTI $160,352,000.00
  • Revenue This Year
  • INZY N/A
  • DTI $4.26
  • Revenue Next Year
  • INZY N/A
  • DTI $6.26
  • P/E Ratio
  • INZY N/A
  • DTI N/A
  • Revenue Growth
  • INZY N/A
  • DTI 8.19
  • 52 Week Low
  • INZY $0.72
  • DTI $1.43
  • 52 Week High
  • INZY $6.24
  • DTI $6.36
  • Technical
  • Relative Strength Index (RSI)
  • INZY 85.93
  • DTI 57.72
  • Support Level
  • INZY $3.94
  • DTI $2.34
  • Resistance Level
  • INZY $3.97
  • DTI $2.79
  • Average True Range (ATR)
  • INZY 0.08
  • DTI 0.23
  • MACD
  • INZY 0.12
  • DTI 0.02
  • Stochastic Oscillator
  • INZY 99.32
  • DTI 70.69

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.

Share on Social Networks: